Cyclosporine opthalmic (Eyenovia/SGN Nanopharma)

环孢素眼科制剂 (Eyenovia/SGN Nanopharma)

Report date: 2026/02/06 20:01:23

Base Information

Drug NameCyclosporine opthalmic (Eyenovia/SGN Nanopharma)

Drug Alias Namecombination product collaboration between SGN Nanopharma’s micellar nanoparticle cyclosporine formulation, SGN-101, and the OptejetEYEN-510

ClassificationSmall molecules > Heterocyclic drugsDrug and medical devices combination products

Mechanisms of ActionP-glycoprotein 1 inhibitorsCalcineurin inhibitorsMitocliondrial permeability transition pore inhibitors +[4]

TargetsP-glycoprotein 1CalcineurinMitocliondrial permeability transition pore +[4]

Therapy Area/IndicationsXerophthalmia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEyenovia Inc

China Registration ClassN/A

Develop Information

Active CompaniesEyenovia Inc

Inactive CompaniesN/A

Active IndicationsXerophthalmia

Inactive IndicationsN/A

Other Information

ATC CodeN/A